Bank of America
FLNA

Bank of America’s Filana Therapeutics FLNA Stock Holding History

Bank of America’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-647,700
Closed -$1.53M – 8524
2024
Q4 		$1.53M Buy
647,700
+5,400
+0.8% +$94.8K ﹤0.01% 4673
2024
Q3 		$18.9M Buy
642,300
+479,600
+295% +$11M ﹤0.01% 2450
2024
Q2 		$2.01M Buy
162,700
+33,300
+26% +$702K ﹤0.01% 4439
2024
Q1 		$2.63M Buy
129,400
+18,200
+16% +$419K ﹤0.01% 4227
2023
Q4 		$2.5M Sell
111,200
-676,700
-86% -$14.3M ﹤0.01% 4185
2023
Q3 		$13.1M Buy
787,900
+588,000
+294% +$11.7M ﹤0.01% 2455
2023
Q2 		$4.9M Hold
199,900
– – ﹤0.01% 3429
2023
Q1 		$4.82M Buy
199,900
+127,100
+175% +$3.52M ﹤0.01% 3573
2022
Q4 		$2.15M Sell
72,800
-222,100
-75% -$7.98M ﹤0.01% 4193
2022
Q3 		$12.3M Buy
294,900
+192,900
+189% +$5.21M ﹤0.01% 2401
2022
Q2 		$2.87M Buy
102,000
+101,800
+50,900% +$2.57M ﹤0.01% 3965
2022
Q1 		$7K Sell
200
-199,800
-100% -$8.47M ﹤0.01% 7828
2021
Q4 		$8.74M Buy
200,000
+100,000
+100% +$5.24M ﹤0.01% 3068
2021
Q3 		$6.21M Sell
100,000
-17,800
-15% -$1.49M ﹤0.01% 3349
2021
Q2 		$10.1M Buy
+117,800
New +$6.31M ﹤0.01% 2856

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America's FLNA Position: Q1 2026 in Review

Bank of America sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 13,531 shares — an estimated $26.8K sold.

Bank of America first reported a position in FLNA in Q2 2013 and held it in 51 quarters. The position peaked at $12M in Q4 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Bank of America reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 13,531 Filana Therapeutics shares in Q1 2026, an estimated $26.8K.
  • Bank of America first reported a position in Filana Therapeutics in Q2 2013 and held it in 51 quarters.
  • Bank of America's Filana Therapeutics position peaked at $12M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.